Divi's Laboratories Limited

NSE:DIVISLAB.NS

Sector

🏥 Health Care

Industries

🌿 Fertilizers

💄 Cosmetics

💊 Drugstores & Retail Pharmacies

💊 Pharmaceuticals

Location

India

Market Cap

USD 21.28 B

Share Price

USD 79.54

Avg Daily Volume

534,876

Change (1 day)

-0.34%

Change (1 year)

45.08%

Change (YTD)

11.64%

Divi's Laboratories Limited EBITDA for the year ending March 31, 2024: USD 304.88 M

Divi's Laboratories Limited EBITDA is USD 304.88 M for the year ending March 31, 2024, a -7.66% change year over year. EBITDA means earnings before interest, taxes, depreciation, and amortization, which measures a company's operating performance by excluding non-operating expenses.

Divi's Laboratories Limited EBITDA for the year ending March 31, 2023 was USD 330.18 M, a -37.28% change year over year.
Divi's Laboratories Limited EBITDA for the year ending March 31, 2022 was USD 526.40 M, a 31.83% change year over year.
Divi's Laboratories Limited EBITDA for the year ending March 31, 2021 was USD 399.29 M, a 49.49% change year over year.
Divi's Laboratories Limited EBITDA for the year ending March 31, 2020 was USD 267.10 M, a -8.42% change year over year.

Competitors

Zhangzhou Pientzehuang Pharmaceutical., Ltd

USD 27.61

600436.SS

+0.02 0.08%

BioMarin Pharmaceutical Inc.

USD 58.10

BMRN

-0.72 -1.22%

Kyowa Kirin Co., Ltd.

USD 16.82

4151.T

-0.17 -1.01%

Abbott India Limited

USD 400.55

ABBOTINDIA.NS

-2.40 -0.60%

Sichuan Kelun Pharmaceutical Co., Ltd.

USD 4.63

002422.SZ

+0.00 0.08%

SCHOTT Pharma AG & Co. KGaA

USD 31.03

1SXP.F

-0.21 -0.66%

Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd

USD 7.83

688336.SS

+0.49 6.65%

Dong-E-E-Jiao Co.,Ltd.

USD 7.05

000423.SZ

+0.05 0.68%

Livzon Pharmaceutical Group Inc.

USD 3.78

1513.HK

-0.01 -0.17%

Kangmei Pharmaceutical Co., Ltd.

USD 0.29

600518.SS

-0.00 -0.88%

Chengdu Kanghong Pharmaceutical Group Co., Ltd

USD 4.25

002773.SZ

+0.20 4.93%

China Medical System Holdings Limited

USD 1.56

0867.HK

-0.01 -0.81%

Gland Pharma Limited

USD 21.63

GLAND.NS

+0.13 0.60%

Jilin Aodong Pharmaceutical Group Co., Ltd.

USD 2.48

000623.SZ

+0.04 1.62%

China Resources Double-Crane Pharmaceutical Co.,Ltd.

USD 2.60

600062.SS

-0.03 -1.09%

Beijing Aosaikang Pharmaceutical Co., Ltd.

USD 2.71

002755.SZ

+0.03 1.12%

Shenzhen Hepalink Pharmaceutical Group Co., Ltd.

USD 0.75

9989.HK

+0.04 5.37%

Yifan Pharmaceutical Co., Ltd.

USD 1.98

002019.SZ

-0.02 -1.18%

Concord Biotech Limited

USD 20.98

CONCORDBIO.NS

-0.10 -0.49%

China Resources Boya Bio-pharmaceutical Group Co., Ltd.

USD 3.67

300294.SZ

+0.02 0.42%

Key Data

Date	EBITDA	Net Income	EPS (Diluted)	Shares (Diluted, Weighted)